UC San Diego has received a five-year, $8 Million grant to support a NIDA P30 Center to investigate the genetics, genomics, and epigenetics behind substance use disorders.
A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.
Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.
A study that used a specialized type of magnetic resonance imaging (MRI), named neuromelanin-sensitive MRI, showed that this type of MRI signal was increased in regions of the midbrain in young adults ages 20 to 24 who had an extensive alcohol and drug use history. The findings are published early online in the American Journal of Psychiatry.
According to new research from UC San Diego School of Medicine, men and women rely on different biological systems for pain relief, which could help explain why our most powerful pain medications are often less effective in women.
As cannabidiol products — commonly known as CBD — become more readily available, West Virginia University researchers are working to gain a broader understanding of how the substance influences driving performance and whether the effects differ between men and women.
In response to President Biden's call to reclassify marijuana, the DEA began the process of rescheduling marijuana from a Schedule I to Schedule III drug. ...
The University of Arkansas at Little Rock has received $5 million in federal funding to address the growing drug and opioid crisis among youth in Arkansas. The award comes from appropriations language authored by U.S. Sen. John Boozman passed into law in 2024. The funding is administered by the Office of National Drug Control Policy.
Leading experts from across the world will join forces in the UK this week in a bid to confront the wide-reaching challenges and curb the devastating effects of gambling.
The Rothman Orthopaedic Institute Foundation for Opioid Research & Education announces a symposium titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis" to be held on November 23, 2024, from 8:30 am to 12:30 pm at the Bluemle Life Science Building at Jefferson Med in Philadelphia.
People with alcohol use disorder (AUD) who are at risk of advanced liver disease are less likely to be referred for liver evaluation and care if they present primarily with alcohol-related mental health issues or a mental health diagnosis, according to a study of referral practices in Virginia’s largest health system. The findings point to the possibility of widespread missed opportunities for treating three conditions that commonly co-occur: AUD, mental health disorders, and liver disease. Recent years have seen notable increases in the USA in alcohol-related deaths, mental health disorders, and hospital admissions relating to alcohol use and concurrent mental health conditions. AUD is a significant cause of liver disease, and both addiction and co-occurring mental illness can be barriers to successful liver treatment. Integrating AUD treatment, mental health care, and hepatology (liver care) is necessary to improve outcomes, but data suggests this approach is not the norm. For the st
Research findings published Aug. 29 in Addiction Science & Clinical Practice may offer hope. A pilot study showed that a small amount of ketamine can reduce or eliminate the withdrawal symptoms associated with quitting fentanyl.
One in 5 older adults used cannabis products that include THC in the last year. Among them, 20% said they drove within 2 hours of using cannabis, and a similar percentage said they experience at least one potential signs of addiction.
A survey of 50,000 primary and secondary school students has found a clear link between night time phone use, sleep deprivation, cyberbullying and poor mental health.
For many years, addiction research has focused on chemical dependencies like drugs and alcohol. However, new phenomena such as video game and social media addictions are not as extensively studied.
Irvine, Calif., Aug. 20, 2024 — A team of researchers led by the University of California, Irvine has discovered that an antioxidant found in rosemary extract can reduce volitional intakes of cocaine by moderating the brain’s reward response, offering a new therapeutic target for treating addiction. The study, recently published online in the journal Neuron, describes team members’ focus on a region of the brain called the globus pallidus externus, which acts as a gatekeeper that regulates how we react to cocaine.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation’s leading researchers on opioid use disorder, as the inaugural Director of the School’s Kahlert Institute for Addiction Medicine
FAU joins the National Academy of Medicine’s Action Collaborative on Combating Opioid Crises. This pilot project, involving more 80 organizations, aims to enhance coordination and address addiction challenges through collaboration among public, private and nonprofit sectors.